Animal Models of Dysregulated Cardiac Metabolism

被引:20
作者
Bugger, Heiko [1 ]
Byrne, Nikole J. [1 ]
Abel, E. Dale [2 ]
机构
[1] Med Univ Graz, Univ Heart Ctr Graz, Dept Cardiol, Graz, Austria
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA
基金
美国国家卫生研究院; 奥地利科学基金会;
关键词
diabetes; glucose; heart failure; mitochondria; models; animal; FATTY-ACID OXIDATION; MYOCARDIAL SUBSTRATE METABOLISM; ACTIVATED RECEPTOR-GAMMA; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; PRESERVED EJECTION FRACTION; HEART-FAILURE; PRESSURE-OVERLOAD; MOUSE HEARTS; CONTRACTILE DYSFUNCTION; GLUCOSE-OXIDATION;
D O I
10.1161/CIRCRESAHA.122.320334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As a muscular pump that contracts incessantly throughout life, the heart must constantly generate cellular energy to support contractile function and fuel ionic pumps to maintain electrical homeostasis. Thus, mitochondrial metabolism of multiple metabolic substrates such as fatty acids, glucose, ketones, and lactate is essential to ensuring an uninterrupted supply of ATP. Multiple metabolic pathways converge to maintain myocardial energy homeostasis. The regulation of these cardiac metabolic pathways has been intensely studied for many decades. Rapid adaptation of these pathways is essential for mediating the myocardial adaptation to stress, and dysregulation of these pathways contributes to myocardial pathophysiology as occurs in heart failure and in metabolic disorders such as diabetes. The regulation of these pathways reflects the complex interactions of cell-specific regulatory pathways, neurohumoral signals, and changes in substrate availability in the circulation. Significant advances have been made in the ability to study metabolic regulation in the heart, and animal models have played a central role in contributing to this knowledge. This review will summarize metabolic pathways in the heart and describe their contribution to maintaining myocardial contractile function in health and disease. The review will summarize lessons learned from animal models with altered systemic metabolism and those in which specific metabolic regulatory pathways have been genetically altered within the heart. The relationship between intrinsic and extrinsic regulators of cardiac metabolism and the pathophysiology of heart failure and how these have been informed by animal models will be discussed.
引用
收藏
页码:1965 / 1993
页数:29
相关论文
共 244 条
  • [61] Cardiac expression of kinase-deficient 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase inhibits glycolysis, promotes hypertrophy, impairs myocyte function, and reduces insulin sensitivity
    Donthi, RV
    Ye, G
    Wu, CD
    McClain, DA
    Lange, AJ
    Epstein, PN
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (46) : 48085 - 48090
  • [62] A spontaneously hypertensive diet-induced atherosclerosis-prone mouse model of metabolic syndrome
    Dragoljevic, Dragana
    Veiga, Camilla Bertuzzo
    Michell, Danielle L.
    Shihata, Waled A.
    Al-Sharea, Annas
    Head, Geoffrey A.
    Murphy, Andrew J.
    Kraakman, Michael J.
    Lee, Man K. S.
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [63] Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-γ both induce cardiac hypertrophy in mice
    Duan, SZ
    Ivashchenko, CY
    Russell, MW
    Milstone, DS
    Mortensen, RM
    [J]. CIRCULATION RESEARCH, 2005, 97 (04) : 372 - 379
  • [64] Absence of malonyl coenzyme a decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury
    Dyck, Jason R. B.
    Hopkins, Teresa A.
    Bonnet, Sebastien
    Michelakis, Evangelos D.
    Young, Martin E.
    Watanabe, Miho
    Kawase, Yosuke
    Jishage, Kou-ichi
    Lopaschuk, Gary D.
    [J]. CIRCULATION, 2006, 114 (16) : 1721 - 1728
  • [65] Mouse Cardiac Acyl Coenzyme A Synthetase 1 Deficiency Impairs Fatty Acid Oxidation and Induces Cardiac Hypertrophy
    Ellis, Jessica M.
    Mentock, Shannon M.
    DePetrillo, Michael A.
    Koves, Timothy R.
    Sen, Shiraj
    Watkins, Steven M.
    Muoio, Deborah M.
    Cline, Gary W.
    Taegtmeyer, Heinrich
    Shulman, Gerald I.
    Willis, Monte S.
    Coleman, Rosalind A.
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2011, 31 (06) : 1252 - 1262
  • [66] Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation
    Fang, Wei-jin
    Wang, Chun-jiang
    He, Yang
    Zhou, Yu-lu
    Peng, Xiang-dong
    Liu, Shi-kun
    [J]. ACTA PHARMACOLOGICA SINICA, 2018, 39 (01) : 59 - 73
  • [67] Fell DA, 1998, BIOTECHNOL BIOENG, V58, P121, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<121::AID-BIT2>3.3.CO
  • [68] 2-F
  • [69] Mitochondrial pyruvate carrier abundance mediates pathological cardiac hypertrophy
    Fernandez-Caggiano, Mariana
    Kamynina, Alisa
    Francois, Asvi A.
    Prysyazhna, Oleksandra
    Eykyn, Thomas R.
    Krasemann, Susanne
    Crespo-Leiro, Maria G.
    Garcia Vieites, Maria
    Bianchi, Katiuscia
    Morales, Valle
    Domenech, Nieves
    Eaton, Philip
    [J]. NATURE METABOLISM, 2020, 2 (11) : 1223 - +
  • [70] Cardiac branched-chain amino acid oxidation is reduced during insulin resistance in the heart
    Fillmore, Natasha
    Wagg, Cory S.
    Zhang, Liyan
    Fukushima, Arata
    Lopaschuk, Gary D.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2018, 315 (05): : E1046 - E1052